North America
Tags: Canada, Life SciencesBy Richard Y. Cheung, Ph.D., Toronto, Fasken Martineau DuMoulin
Due to concerns about the growing percentage of the health care budget allotted to drug spending in Canada and the relative drug prices in Canada compared to other developed countries, the Canadian government is proposing changes to the way in which prices for patented drugs are regulated …
Read or download the full article below.
Latest Updates
Related Articles
Related Articles by Jurisdiction
The blockchain effect on investment funds
Blockchain was originally considered to be the innovative technology that only supported cryptocurrencies like bitcoin and ethereum ...
Significant changes proposed to Canada’s AML/ATF regime
The Proposed Regulations are wide ranging and include a number of substantive changes as well as technical amendments.
N. America: Northern Gateway Pipeline
Province must consult and decide but may impose conditions
Latest Articles
















